id,sequence,label,source
abituzumab,QVQLQQSGGELAKPGASVKVSCKASMHWVRQAPGQGLEWIGYEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCWGQGTTVTVSS,0,jain2017
abrilumab,QVQLVQSGAEVKKPGASVKVSCKVSIHWVRQAPGKGLEWMGGIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCWGQGTLVTVSS,0,jain2017
adalimumab,EVQLVESGGGLVQPGRSLRLSCAASMHWVRQAPGKGLEWVSADYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
alemtuzumab,QVQLQESGPGLVRPSQTLSLTCTVSMNWVRQPPGRGLEWIGFEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCWGQGSLVTVSS,0,jain2017
alirocumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLDWVSTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCWGRGTLVTVSS,0,jain2017
anifrolumab,EVQLVQSGAEVKKPGESLKISCKGSIAWVRQMPGKGLESMGIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCWGRGTLVTVSS,0,jain2017
belimumab,QVQLQQSGAEVKKPGSSVRVSCKASINWVRQAPGQGLEWMGGKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCWGRGTMVTVSS,1,jain2017
bimagrumab,QVQLVQSGAEVKKPGASVKVSCKASINWVRQAPGQGLEWMGTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCWGQGTLVTVSS,1,jain2017
blosozumab,QVQLVQSGAEVKKPGASVKVSCKVSQHWVRQAPGKGLEWMGWEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCWGQGTTVTVSS,1,jain2017
bococizumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGENYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCWGQGTTVTVSS,1,jain2017
briakinumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVAFYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTMVTVSS,1,jain2017
canakinumab,QVQLVESGGGVVQPGRSLRLSCAASMNWVRQAPGKGLEWVAIYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
carlumab,QVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,1,jain2017
certolizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWMGWIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
cetuximab,QVQLKQSGPGLVQPSQSLSITCTVSVHWVRQSPGKGLEWLGVDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCWGQGTLVTVSA,0,jain2017
cixutumumab,EVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCWGKGTTVTVSS,1,jain2017
clazakizumab,EVQLVESGGGLVQPGGSLRLSCAASVTWVRQAPGKGLEWVGIAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
codrituzumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGAAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCWGQGTLVTVSS,1,jain2017
crenezumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLELVASYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSS,0,jain2017
dacetuzumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVARSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
dalotuzumab,QVQLQESGPGLVKPSETLSLTCTVSWNWIRQPPGKGLEWIGYNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSS,1,jain2017
daratumumab,EVQLLESGGGLVQPGGSLRLSCAVSMSWVRQAPGKGLEWVSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCWGQGTLVTVSS,0,jain2017
denosumab,EVQLLESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVSGYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,1,jain2017
duligotuzumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVGEDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,1,jain2017
dupilumab,EVQLVESGGGLEQPGGSLRLSCAGSMTWVRQAPGKGLEWVSSYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTTVTVSS,1,jain2017
eculizumab,QVQLVQSGAEVKKPGASVKVSCKASIQWVRQAPGQGLEWMGEEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
efalizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGMRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
elotuzumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWIGENYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
emibetuzumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGRTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTTVTVSS,1,jain2017
etrolizumab,EVQLVESGGGLVQPGGSLRLSCAASWGWVRQAPGKGLEWVGYSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCWGQGTLVTVSS,1,jain2017
farletuzumab,EVQLVESGGGVVQPGRSLRLSCSASLSWVRQAPGKGLEWVAMYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCWGQGTPVTVSS,0,jain2017
fasinumab,QVQLVQSGAEVKKPGASVKVSCKVSIHWVRQAPGKGLEWMGGIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
ficlatuzumab,QVQLVQPGAEVKKPGTSVKLSCKASMHWVRQAPGQGLEWIGENYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCWGQGTLLTVSS,0,jain2017
figitumumab,EVQLLESGGGLVQPGGSLRLSCTASMNWVRQAPGKGLEWVSAFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCWGQGTTVTVSS,1,jain2017
fletikumab,QVQLVQSGAEVKRPGASVKVSCKASIHWVRQAPGQRLEWMGWQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCWGQGTTVTVSS,0,jain2017
foralumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVAVYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGRGTLVTVSS,1,jain2017
fresolimumab,QVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
gantenerumab,QVELVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,1,jain2017
gevokizumab,QVQLQESGPGLVKPSQTLSLTCSFSVGWIRQPSGKGLEWLAHSYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCWGQGTLVTVSS,0,jain2017
girentuximab,DVKLVESGGGLVKLGGSLKLSCAASMSWVRQTPEKRLELVAAYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCWGQGTSVTVSS,0,jain2017
guselkumab,EVQLVQSGAEVKKPGESLKISCKGSIGWVRQMPGKGLEWMGIRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCWGQGTLVTVSS,1,jain2017
ibalizumab,QVQLQQSGPEVVKPGASVKMSCKASIHWVRQKPGQGLDWIGYDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
imgatuzumab,QVQLVQSGAEVKKPGSSVKVSCKASIHWVRQAPGQGLEWMGYTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCWGQGTTVTVSS,1,jain2017
inotuzumab,EVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQGLEWIGGTYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCWGQGTLVTVSS,1,jain2017
ixekizumab,QVQLVQSGAEVKKPGSSVKVSCKASIHWVRQAPGQGLEWMGVDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,1,jain2017
lenzilumab,QVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQRLEWMGWKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,1,jain2017
lintuzumab,QVQLVQSGAEVKKPGSSVKVSCKASMHWVRQAPGQGLEWIGYGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
lumiliximab,EVQLVESGGGLAKPGGSLRLSCAASMDWVRQAPGQGLEWVSRWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCWGQGVLVTVSS,0,jain2017
matuzumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWIGENYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
mavrilimumab,QVQLVQSGAEVKKPGASVKVSCKVSIHWVRQAPGKGLEWMGGVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCWGQGTMVTVSS,0,jain2017
mepolizumab,QVTLRESGPALVKPTQTLTLTCTVSVHWVRQPPGKGLEWLGVDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCWGRGTPVTVSS,0,jain2017
mogamulizumab,EVQLVESGGDLVQPGRSLRLSCAASMSWVRQAPGKGLEWVATYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCWGQGTLVTVSS,0,jain2017
muromonab,QVQLQQSGAELARPGASVKMSCKASMHWVKQRPGQGLEWIGYNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCWGQGTTLTVSS,0,jain2017
natalizumab,QVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQRLEWMGRKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
necitumumab,QVQLQESGPGLVKPSQTLSLTCTVSWSWIRQPPGKGLEWIGYDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCWGQGTLVTVSS,0,jain2017
nivolumab,QVQLVESGGGVVQPGRSLRLDCKASMHWVRQAPGKGLEWVAVYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
obinutuzumab,QVQLVQSGAEVKKPGSSVKVSCKASINWVRQAPGQGLEWMGRDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
ofatumumab,EVQLVESGGGLVQPGRSLRLSCAASMHWVRQAPGKGLEWVSTGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCWGQGTTVTVSS,0,jain2017
olokizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVAQYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCWGQGTLVTVSS,0,jain2017
omalizumab,EVQLVESGGGLVQPGGSLRLSCAVSWNWIRQAPGKGLEWVASNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
onartuzumab,EVQLVESGGGLVQPGGSLRLSCAASLHWVRQAPGKGLEWVGMRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
otlertuzumab,EVQLVQSGAEVKKPGESLKISCKGSMNWVRQMPGKGLEWMGNTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCWGQGTLVTVSS,0,jain2017
ozanezumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWIGNNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,1,jain2017
palivizumab,QVTLRESGPALVKPTQTLTLTCTFSVGWIRQPPGKALEWLADDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCWGAGTTVTVSS,0,jain2017
panitumumab,QVQLQESGPGLVKPSETLSLTCTVSWTWIRQSPGKGLEWIGHNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCWGQGTMVTVSS,0,jain2017
panobacumab,EEQVVESGGGFVQPGGSLRLSCAASMHWVRQAPGKGLVWVSRYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCWGQGTMVTVSS,0,jain2017
parsatuzumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGDHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,1,jain2017
patritumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQPPGKGLEWIGENYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCWGRGTLVTVSS,1,jain2017
pertuzumab,EVQLVESGGGLVQPGGSLRLSCAASMDWVRQAPGKGLEWVADIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCYWGQGTLVTVS,0,jain2017
pinatuzumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGRNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
polatuzumab,EVQLVESGGGLVQPGGSLRLSCAASIEWVRQAPGKGLEWIGENYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
ponezumab,QVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQGLEWMGRKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCWGQGTTVTVSS,1,jain2017
radretumab,EVQLLESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVSSYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
ramucirumab,EVQLVQSGGGLVKPGGSLRLSCAASMNWVRQAPGKGLEWVSSYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTMVTVSS,0,jain2017
ranibizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGWTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,1,jain2017
reslizumab,EVQLVESGGGLVQPGGSLRLSCAVSVNWIRQAPGKGLEWVGLDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
robatumumab,EVQLVQSGGGLVKPGGSLRLSCAASMHWVRQAPGKGLEWISVYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSS,1,jain2017
romosozumab,EVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGEGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTTVTVSS,0,jain2017
sarilumab,EVQLVESGGGLVQPGRSLRLSCAASMHWVRQAPGKGLEWVSGGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCWGQGTMVTVSS,0,jain2017
secukinumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVAAYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCWGRGTLVTVSS,0,jain2017
siltuximab,EVQLVESGGKLLKPGGSLKLSCAASMSWFRQSPEKRLEWVAEYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCWGQGTSVTVSS,0,jain2017
simtuzumab,QVQLVQSGAEVKKPGASVKVSCKASIEWVRQAPGQGLEWIGVNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCWGQGTTVTVSS,1,jain2017
sirukumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVAKYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSS,1,jain2017
tabalumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQPPGKGLEWIGENYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSS,0,jain2017
tigatuzumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVATYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
tildrakizumab,QVQLVQSGAEVKKPGASVKVSCKASMTWVRQAPGQGLEWMGQDYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTLVTVSS,0,jain2017
tocilizumab,QVQLQESGPGLVRPSQTLSLTCTVSWSWVRQPPGRGLEWIGYTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCWGQGSLVTVSS,0,jain2017
tovetumab,QVQLVESGGGLVKPGGSLRLSCAASMNWIRQAPGKGLEWVSYYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSS,0,jain2017
trastuzumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVARRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSS,0,jain2017
ustekinumab,EVQLVQSGAEVKKPGESLKISCKGSLGWVRQMPGKGLDWIGIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCWGQGTLVTVSS,1,jain2017
vedolizumab,QVQLVQSGAEVKKPGASVKVSCKGSMHWVRQAPGQRLEWIGENYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,0,jain2017
veltuzumab,QVQLQQSGAEVKKPGSSVKVSCKASMHWVKQAPGQGLEWIGASYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCWGQGTTVTVSS,0,jain2017
visilizumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGYHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCWGQGTLVTVSS,1,jain2017
zanolimumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQPPGKGLEWIGENYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSS,0,jain2017
